Cleared Traditional

K884922 - THE BREATHE EASE NURSERY VAPOR TENT (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K884922 · Cal-Trends Products · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1989
Decision
67d
Days
Class 2
Risk

K884922 is an FDA 510(k) clearance for the THE BREATHE EASE NURSERY VAPOR TENT. Classified as Tent, Pediatric Aerosol (product code FNC), Class II - Special Controls.

Submitted by Cal-Trends Products (Fullerton, US). The FDA issued a Cleared decision on February 3, 1989 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5710 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cal-Trends Products devices

Submission Details

510(k) Number K884922 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 1988
Decision Date February 03, 1989
Days to Decision 67 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 139d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FNC Tent, Pediatric Aerosol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5710
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.